A risk prediction index for amiodarone-induced thyrotoxicosis in adults with congenital heart disease

Marius N. Stan, Erik P. Hess, Rebecca S. Bahn, Carole A. Warnes, Naser M. Ammash, Michael D. Brennan, Prabin Thapa, Victor M. Montori

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Amiodarone therapy in adults with congenital heart disease (CHD) is associated with a significant risk of amiodarone-induced thyrotoxicosis (AIT). We developed a risk index to identify those patients being considered for amiodarone treatment who are at high risk for AIT. We reviewed the health records of adults with CHD and assessed the association between potential clinical predictors and AIT. Significant predictors were included in multivariate analyses. The parameter estimates from multivariate analysis were subsequently used to develop a risk index. 169 adults met eligibility criteria and 23 developed AIT. The final model included age, cyanotic heart disease and BMI. The risk index developed identified 3 categories of risk. Their AIT likelihood ratios were: 0.37 for low risk (95% CI 0.150.92); 1.12 for medium risk (95% CI 0.651.91); and 3.47 for high risk (95% CI 1.77.11). The AIT predicted risk in our population was 5% for the low risk group, 15% for the medium risk group and 47% for the high risk group. Conclusions. We derived the first model to quantify the risk for developing AIT among adults with CHD. Before using it clinically to help selecting among alternative antiarrhythmic options, it needs validation in an independent population.

Original languageEnglish (US)
Article number210529
JournalJournal of Thyroid Research
StatePublished - 2012

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'A risk prediction index for amiodarone-induced thyrotoxicosis in adults with congenital heart disease'. Together they form a unique fingerprint.

Cite this